Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents Read more about Supernus Sues Actavis for Infringement of Trokendi XR(R) Patents
Supernus Announces Issuance of Fourth US Patent Protecting Oxtellar XR® Read more about Supernus Announces Issuance of Fourth US Patent Protecting Oxtellar XR®
Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R) Read more about Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R)
Supernus to Attend FBR HealthCare Conference in September Read more about Supernus to Attend FBR HealthCare Conference in September
Supernus Receives FDA Fast Track Designation for SPN-810 Read more about Supernus Receives FDA Fast Track Designation for SPN-810
Supernus Announces Second Quarter 2014 Results Read more about Supernus Announces Second Quarter 2014 Results
Supernus to Host Second Quarter 2014 Earnings Conference Call Read more about Supernus to Host Second Quarter 2014 Earnings Conference Call
Supernus to Receive $30 Million in Non-Dilutive Royalty Deal Read more about Supernus to Receive $30 Million in Non-Dilutive Royalty Deal
Supernus to Present at Jefferies Healthcare Conference in June Read more about Supernus to Present at Jefferies Healthcare Conference in June